Avantor (AVTR) to Release Earnings on Wednesday

Avantor (NYSE:AVTRGet Free Report) will be announcing its 12/31/2023 earnings results before the market opens on Wednesday, February 14th. Analysts expect the company to announce earnings of $0.22 per share for the quarter. Investors that are interested in registering for the company’s conference call can do so using this link.

Avantor Trading Down 2.8 %

NYSE AVTR opened at $22.56 on Tuesday. The company has a debt-to-equity ratio of 1.04, a current ratio of 1.60 and a quick ratio of 1.03. The firm’s fifty day moving average price is $22.40 and its 200 day moving average price is $21.18. The company has a market capitalization of $15.26 billion, a price-to-earnings ratio of 41.77, a price-to-earnings-growth ratio of 1.42 and a beta of 1.36. Avantor has a 12 month low of $16.63 and a 12 month high of $25.25.

Hedge Funds Weigh In On Avantor

Several hedge funds have recently added to or reduced their stakes in AVTR. Raymond James Trust N.A. grew its holdings in shares of Avantor by 28.8% during the first quarter. Raymond James Trust N.A. now owns 7,342 shares of the company’s stock worth $248,000 after buying an additional 1,643 shares in the last quarter. Delphia USA Inc. acquired a new stake in shares of Avantor in the fourth quarter worth approximately $233,000. Meiji Yasuda Asset Management Co Ltd. acquired a new stake in shares of Avantor in the second quarter worth approximately $225,000. Alberta Investment Management Corp acquired a new stake in shares of Avantor in the first quarter worth approximately $222,000. Finally, Sherbrooke Park Advisers LLC acquired a new stake in shares of Avantor in the second quarter worth approximately $219,000. 89.04% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

A number of research analysts recently commented on AVTR shares. Deutsche Bank Aktiengesellschaft increased their target price on shares of Avantor from $20.00 to $22.00 and gave the company a “hold” rating in a research report on Tuesday, December 12th. TD Cowen raised shares of Avantor from a “market perform” rating to an “outperform” rating and increased their target price for the company from $21.00 to $28.00 in a research report on Monday, December 11th. The Goldman Sachs Group increased their price target on shares of Avantor from $23.00 to $26.00 and gave the stock a “buy” rating in a research note on Thursday, December 7th. Royal Bank of Canada restated an “outperform” rating and issued a $28.00 target price on shares of Avantor in a research note on Tuesday, January 9th. Finally, Wolfe Research began coverage on shares of Avantor in a research note on Wednesday, December 13th. They issued a “peer perform” rating for the company. Four analysts have rated the stock with a hold rating and nine have issued a buy rating to the company’s stock. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average target price of $24.55.

Check Out Our Latest Stock Analysis on Avantor

Avantor Company Profile

(Get Free Report)

Avantor, Inc engages in the provision of mission-critical products and services to customers in biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.

Featured Stories

Earnings History for Avantor (NYSE:AVTR)

Receive News & Ratings for Avantor Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avantor and related companies with MarketBeat.com's FREE daily email newsletter.